Skip to main content
USAID

USAID's Neglected Tropical Diseases Program
USAID's Neglected Tropical Disease Program

  • NTDs thrive under conditions of poverty, poor sanitation, unsafe water, and malnutrition
  • NTDs can blind, deform, and debilitate their victims
  • NTDs compromise mental and physical development, reduce school enrollment, and hinder economic productivity
  • Preventing NTDs attacks a root cause of poverty that affects a significant proportion of the world’s population
  • Safe and effective drugs are now available to prevent the most common NTDs

Latest News

Go to Newsroom
Jan
26

The Liverpool School of Tropical Medicine Announces £3 Billion Ross Fund to Support the Global Fight Against Infectious Diseases

Along with the support for malaria and other infectious diseases, the fund will allocate £200 million to Neglected Tropical Diseases (NTDs) and over £300 million fighting antimicrobial resistance.

Read More


Nov
18

Video: Global Trachoma Mapping Project

USAID is a partner in the Global Trachoma Mapping Project, the largest mapping project in history. By the time the project ends in 2015, it will have mapped the global prevalence of trachoma in three years.

Watch the Video


Nov
16

Bringing NTDs into Sharp Focus: A Joint Vision for Better Sight in Ethiopia

Devex provides a closer look at the global fight against NTDs through a series of exclusive interviews with partners, including USAID, working on the frontlines of NTD control and elimination efforts in Ethiopia.

Read More


Oct
7

VOA's Africa 54 News Highlights Nobel Prize Winners

Voice of America's Africa 54 News highlights the work of the recent Nobel Prize winners who discovered therapies to treat some of the most devastating parasitic diseases in the world.

Read More


Sep
25

3 Scientists Win Nobel Prize in Medicine for Parasite-Fighting Therapies

Three scientists were awarded the Nobel Prize in Physiology or Medicine for discovering therapies to treat some of the most devastating parasitic diseases in the world. Their award-winning therapies include Ivermectin, which USAID utilizes to help combat river blindness and filariasis.

Read More


Sep
25

New Information on Merck Mectizan Donation Program Available

USAID pharmaceutical partner Merck has new information available regarding their Mectizan donation program. Mectizan is used to curb onchoceriasis and lymphatic filariasis throughout the Americas.

Read More


Blog

A child leads a blind woman along a path to the village

A Great New Partnership to Expand Access to Filiaris Test Strips

A new diagnostic test enabling countries to determine when to stop large-scale treatment of populations to eliminate lymphatic filariasis is now available. The Filariasis Test Strip is a new point-of-care rapid diagnostic test designed to detect in human blood the antigen of the major species of filarial worm that causes lymphatic filariasis.

Blog

A child leads a blind woman along a path to the village

Global Partners Celebrate the Donation of 500 Millionth Dose of Zithromax®

The International Trachoma Initiative,Pfizer, Inc., and the International Coalition for Trachoma Control celebrate Pfizer's donation of the 500 millionth dose of Zithromax®, a critical antibiotic used to prevent and treat trachoma.